Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination

Two large pivotal phase III studies demonstrated the efficacy of the tetravalent dengue vaccine (CYD-TDV; Dengvaxia®, Sanofi Pasteur) against all dengue serotypes. Here we present an unprecedented integrated summary of the immunogenicity of CYD-TDV to identify the parameters driving the neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Vigne, Claire, Dupuy, Martin, Richetin, Aline, Guy, Bruno, Jackson, Nicholas, Bonaparte, Matthew, Hu, Branda, Saville, Melanie, Chansinghakul, Danaya, Noriega, Fernando, Plennevaux, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612045/
https://www.ncbi.nlm.nih.gov/pubmed/28598256
http://dx.doi.org/10.1080/21645515.2017.1333211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5612045/
https://www.ncbi.nlm.nih.gov/pubmed/28598256
http://dx.doi.org/10.1080/21645515.2017.1333211

Ejemplares similares